InvestorsHub Logo
Followers 45
Posts 5645
Boards Moderated 0
Alias Born 04/05/2015

Re: None

Sunday, 03/10/2019 10:17:15 AM

Sunday, March 10, 2019 10:17:15 AM

Post# of 701097
From the UK Brain Tumor Charity Brains Trust:-

Brain tumour immunotherapy, particularly DCVax®, is gaining an increasing amount of media coverage and interest. We are seeing a growing number of calls to our support helpline about DCVax® and brain tumour immunotherapy. This Know How sheds some light on the current state of play for one particular brain tumour immunotherapy trial and some recently published results.



Awareness of DCVax appears to be growing all the time in the UK.

Tha accompanying Know How fact sheet, produced by the Charity is quite good, and gives an accurate state of play on the trial and the interim data, and the only method of current availability via the UK Specials Programme.
I suspect the waiting list for this scheme that NWBO is managing is getting bigger.

I really don't think that, after approval, any advertising of DCVaxL will be necessary, nor any change of name.
Why change what is going to become a byword?

https://brainstrust.org.uk/brain-tumour-support/quality-of-life/practical-help/knowhows/

https://brainstrust.org.uk/wp-content/uploads/2019/03/brainstrust-know-hows-immunotherapy-10.02.19-1.pdf
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News